{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:44:35Z","timestamp":1786628675834,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is a lifespan condition associated with substantial morbidity, premature mortality, and high healthcare utilization, particularly due to acute pain crises and other severe complications. Evidence-based guidelines emphasize the importance of comprehensive, multidisciplinary care for optimal outcomes; however, implementation of such models for adults with SCD remains inconsistent, contributing to fragmented care and reliance on emergency services. The primary aim of the study is to evaluate the implementation and impact of a National Alliance of Sickle Cell Centers (NASCC) aligned comprehensive adult SCD center on outpatient engagement, infusion therapy utilization, and acute care use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The University of Alabama at Birmingham implemented a multidisciplinary adult SCD center beginning in 2019. We conducted a retrospective, population-based evaluation comparing care engagement and utilization before (January 2017\u2013December 2018) and after (January 2022\u2013December 2024) center implementation, excluding the COVID-19 period. Electronic medical record data were used to identify adults with SCD and capture outpatient clinic visits, infusion therapy unit use, emergency department (ED) visits, and hospitalizations. Nonparametric statistical tests were used to compare outcomes across periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The adult SCD clinic population increased more than three-fold, reaching 810 patients by 2024, alongside substantial expansion of clinical space, staffing, and infusion capacity. By 2024, nearly 90% of patients with SCD were seen annually in the outpatient clinic. Infusion therapy visits increased fifteen-fold, providing an alternative to ED-based pain management. Mean acute care visits per person per year decreased significantly from 2.11 to 1.26, while mean routine outpatient visits per person per year increased from 2.65 to 5.32 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Reductions in ED visits and hospitalizations were observed despite a marked increase in the total population served.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Implementation of a NASCC-aligned comprehensive adult SCD center was associated with improved outpatient engagement, expanded access to preventive and infusion-based care, and significant reductions in acute care utilization. These findings provide real-world evidence that comprehensive, multidisciplinary SCD centers are an effective structural strategy to improve care delivery and outcomes for adults living with SCD and support broader adoption of this model to advance equity and value-based care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-026-15206-6","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:44:52Z","timestamp":1784875492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of a comprehensive sickle cell center leads to improved access to care and decreased acute care use"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-8891","authenticated-orcid":false,"given":"Julie","family":"Kanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Plaxco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najibah","family":"Galadanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Helleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lebensburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"4 Suppl","key":"15206_CR1","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512\u201321.","journal-title":"Am J Prev Med"},{"key":"15206_CR2","unstructured":"Prevention C. f.D.C.a. Data and statistics on sickle cell disease. 2024 May 15, 2024 [cited 2025 December, 12]; Available from: https:\/\/www.cdc.gov\/sickle-cell\/data\/index.html."},{"issue":"10","key":"15206_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033\u201348.","journal-title":"JAMA"},{"key":"15206_CR4","unstructured":"Prevention C. f.D.C.a. Sickle Cell Data Collection (SCDC) Program. 2024 [cited 2025 December, 12]; Available from: https:\/\/www.cdc.gov\/sickle-cell\/scdc\/index.html."},{"issue":"20","key":"15206_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.1997.03550200063033","volume":"278","author":"G Ellrodt","year":"1997","unstructured":"Ellrodt G, et al. Evidence-based disease management. JAMA. 1997;278(20):1687\u201392.","journal-title":"JAMA"},{"key":"15206_CR6","unstructured":"Hematology ASo. ASH Clinical Practice Guidelines on Sickle Cell Disease. 2024 [cited 2025 December 12]; Available from: https:\/\/www.hematology.org\/education\/clinicians\/guidelines-and-quality-care\/clinical-practice-guidelines\/sickle-cell-disease-guidelines."},{"issue":"12","key":"15206_CR7","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","volume":"4","author":"AM Brandow","year":"2020","unstructured":"Brandow AM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4(12):2656\u2013701.","journal-title":"Blood Adv"},{"issue":"3","key":"15206_CR8","doi-asserted-by":"publisher","first-page":"e201737","DOI":"10.1001\/jamanetworkopen.2020.1737","volume":"3","author":"F Farooq","year":"2020","unstructured":"Farooq F, et al. Comparison of US Federal and Foundation Funding of Research for Sickle Cell Disease and Cystic Fibrosis and Factors Associated With Research Productivity. JAMA Netw Open. 2020;3(3):e201737.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"15206_CR9","doi-asserted-by":"publisher","first-page":"e213467","DOI":"10.1001\/jamahealthforum.2021.3467","volume":"2","author":"J Kanter","year":"2021","unstructured":"Kanter J, et al. Improving Outcomes for Patients With Sickle Cell Disease in the United States: Making the Case for More Resources, Surveillance, and Longitudinal Data. JAMA Health Forum. 2021;2(10):e213467.","journal-title":"JAMA Health Forum"},{"key":"15206_CR10","volume-title":"Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action","year":"2020","unstructured":"Martinez RM, Osei-Anto HA, McCormick M, editors. Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action. Editors: Washington (DC); 2020."},{"issue":"11","key":"15206_CR11","doi-asserted-by":"publisher","first-page":"e2543421","DOI":"10.1001\/jamanetworkopen.2025.43421","volume":"8","author":"SA Jacob","year":"2025","unstructured":"Jacob SA, et al. National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A Consensus Statement. JAMA Netw Open. 2025;8(11):e2543421.","journal-title":"JAMA Netw Open"},{"issue":"18","key":"15206_CR12","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1182\/bloodadvances.2025015909","volume":"9","author":"SH Guarino","year":"2025","unstructured":"Guarino SH, et al. National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease. Blood Adv. 2025;9(18):4585\u201391.","journal-title":"Blood Adv"},{"issue":"3","key":"15206_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0033354919839072","volume":"134","author":"AB Snyder","year":"2019","unstructured":"Snyder AB, et al. Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease. Public Health Rep. 2019;134(3):274\u201381.","journal-title":"Public Health Rep"},{"issue":"18","key":"15206_CR14","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1182\/bloodadvances.2025017088","volume":"9","author":"G Pollock","year":"2025","unstructured":"Pollock G, Curtis S. A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease. Blood Adv. 2025;9(18):4622\u20133.","journal-title":"Blood Adv"},{"issue":"4","key":"15206_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/QCO.0000000000001027","volume":"37","author":"S Abbas","year":"2024","unstructured":"Abbas S, Stevens MP. Horizontal versus vertical strategies for infection prevention: current practices and controversies. Curr Opin Infect Dis. 2024;37(4):282\u20139.","journal-title":"Curr Opin Infect Dis"},{"key":"15206_CR16","doi-asserted-by":"crossref","unstructured":"Hall GL. Delivering consistent and equitable healthcare. In: G.L. Hall, Editor, patient-centered clinical care for african americans: a concise, evidence-based guide to important differences and better outcomes. 2020, Springer International Publishing: Cham. pp. 23\u201335.","DOI":"10.1007\/978-3-030-26418-5_3"},{"key":"15206_CR17","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.blre.2024.101194","volume":"65","author":"P Telfer","year":"2024","unstructured":"Telfer P, et al. The acute pain crisis in sickle cell disease: What can be done to improve outcomes? Blood Rev. 2024;65:101194.","journal-title":"Blood Rev"},{"key":"15206_CR18","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2147\/JPR.S185582","volume":"11","author":"SN Uwaezuoke","year":"2018","unstructured":"Uwaezuoke SN, et al. Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management. J Pain Res. 2018;11:3141\u201350.","journal-title":"J Pain Res"},{"issue":"5","key":"15206_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/1359105314539530","volume":"21","author":"SM Bediako","year":"2016","unstructured":"Bediako SM, et al. The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust study. J Health Psychol. 2016;21(5):808\u201320.","journal-title":"J Health Psychol"},{"issue":"7","key":"15206_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jpain.2006.05.004","volume":"7","author":"KH Todd","year":"2006","unstructured":"Todd KH, et al. Sickle cell disease related pain: crisis and conflict. J Pain. 2006;7(7):453\u20138.","journal-title":"J Pain"},{"issue":"11","key":"15206_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/bmjqs-2024-017725","volume":"34","author":"I Osunkwo","year":"2025","unstructured":"Osunkwo I, et al. Results of a healthcare transition learning collaborative for emerging adults with sickle cell disease: the ST3P-UP study transition quality improvement collaborative. BMJ Qual Saf. 2025;34(11):747\u201357.","journal-title":"BMJ Qual Saf"},{"issue":"4","key":"15206_CR22","doi-asserted-by":"publisher","first-page":"e30160","DOI":"10.1002\/pbc.30160","volume":"70","author":"S Sheppard","year":"2023","unstructured":"Sheppard S, et al. Assessing barriers and facilitators to transition in sickle cell disease care prior to implementation of a formalized program. Pediatr Blood Cancer. 2023;70(4):e30160.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"15206_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/ajh.27407","volume":"99","author":"C Torres","year":"2024","unstructured":"Torres C, et al. Real-world implementation of the David-Carroll buprenorphine protocol for pain management in sickle cell disease. Am J Hematol. 2024;99(9):1834\u20136.","journal-title":"Am J Hematol"},{"key":"15206_CR24","doi-asserted-by":"publisher","first-page":"E74","DOI":"10.5888\/pcd21.240138","volume":"21","author":"DJ Bilicki","year":"2024","unstructured":"Bilicki DJ, Reeves MJ. Outpatient Follow-Up Visits to Reduce 30-Day All-Cause Readmissions for Heart Failure, COPD, Myocardial Infarction, and Stroke: A Systematic Review and Meta-Analysis. Prev Chronic Dis. 2024;21:E74.","journal-title":"Prev Chronic Dis"},{"issue":"20","key":"15206_CR25","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1182\/bloodadvances.2023012439","volume":"8","author":"L Siewny","year":"2024","unstructured":"Siewny L, et al. Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department. Blood Adv. 2024;8(20):5330\u20138.","journal-title":"Blood Adv"},{"issue":"5","key":"15206_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1188\/15.CJON.562-567","volume":"19","author":"N Matthie","year":"2015","unstructured":"Matthie N, Jenerette C. Sickle cell disease in adults: developing an appropriate care plan. Clin J Oncol Nurs. 2015;19(5):562\u20137.","journal-title":"Clin J Oncol Nurs"},{"issue":"5","key":"15206_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jpainsymman.2014.02.002","volume":"48","author":"C Haywood Jr","year":"2014","unstructured":"Haywood C Jr., et al. Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease. J Pain Symptom Manage. 2014;48(5):934\u201343.","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"15206_CR28","first-page":"1050","volume":"102","author":"CM Jenerette","year":"2010","unstructured":"Jenerette CM, Brewer C. Health-related stigma in young adults with sickle cell disease. J Natl Med Assoc. 2010;102(11):1050\u20135.","journal-title":"J Natl Med Assoc"},{"issue":"7","key":"15206_CR29","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s11136-025-03963-6","volume":"34","author":"J Drahos","year":"2025","unstructured":"Drahos J, et al. Health-related quality of life and economic impacts in adults with sickle cell disease with recurrent vaso-occlusive crises: findings from a prospective longitudinal real-world survey. Qual Life Res. 2025;34(7):2019\u201329.","journal-title":"Qual Life Res"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15206-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:25:19Z","timestamp":1786627519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-15206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15206"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-15206-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from the IRB at the University of Alabama Birmingham. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The need for informed consent was waived by the IRB that approved this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors gave consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1118"}}